Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study investigates 'Sluggish cognitive Tempo' in FND patients

NCT ID NCT07451821

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 11, 2026 · Updated 5 times

Summary

This study will compare symptoms of sluggish cognitive tempo (also called cognitive disengagement syndrome) in 100 adults with Functional Neurological Symptom Disorder against healthy controls. Participants will fill out questionnaires about daydreaming, confusion, and slow thinking. The goal is to see if these cognitive symptoms are more common in people with FND.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study finds a link, it could help doctors better understand and recognize cognitive symptoms in people with Functional Neurological Symptom Disorder.
What could go wrong
This is an early observational study with only 100 participants, so results may not apply to everyone. It looks at symptoms, not treatments, so it won't directly change care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adult participants aged 18-65 years. The Functional Neurological Symptom Disorder (FNSD) group will include consecutive subjects diagnosed with FNSD according to DSM-5-TR criteria who will be admitted to the psychiatry clinic of Elazığ Mental Health and Diseases Hospital (Turkey). The healthy control (HC) group will consist of individuals from the general population who will apply to the hospital medical board and will have no current or past psychiatric or significant medical disorders. All participants will provide informed consent prior to enrollment.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* Inclusion Criteria for the Functional Neurological Symptom Disorder (FNSD) Group: 1. Meeting the diagnostic criteria for FNSD/CD according to DSM-5-TR at the time of admission 2. Being between 18-65 years of age 3. Absence of additional psychiatric disorders 4. Absence of alcohol/substance use disorder 5. Absence of neurological disorders affecting cognition 6. Being in remission with FNSD/CD 7. Completing sociodemographic data fully 8. Willingness to complete the forms and scales. 9. Willingness to participate in the study * Exclusion Criteria for the FNSD Group: 1. Being under 18 or over 65 years of age 2. Not meeting the diagnostic criteria for FNSD/CD according to DSM-5-TR 3. Active alcohol/substance use 4. Having neurological diseases affecting cognitive functions (such as Alzheimer's disease, delirium, Parkinson's disease) 5. Not being willing to participate in the study 6. Incomplete sociodemographic data 7. Not being willing to complete forms and scales. * Inclusion Criteria for the Healthy Control (HC) Group 1. Being between 18-65 years of age 2. Not having any psychiatric disorder 3. Not having an alcohol/substance use disorder 4. Not having a neurological disorder affecting cognition 5. Completing sociodemographic data in full 6. Being willing to complete the forms and scales. 7. Being willing to participate in the study * Exclusion Criteria for the HC Group: 1. Being under 18 or over 65 years of age 2. Having a psychiatric disorder 3. Active alcohol/substance use 4. Having neurological diseases affecting cognitive functions (such as Alzheimer's disease, delirium, Parkinson's disease) 5. Not being willing to participate in the study 6. Incomplete sociodemographic data 7. Not being willing to complete forms and scales.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional neurological symptom disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Elazığ Mental Health and Diseases Hospital

    RECRUITING

    Elâzığ, Elâzığ, 23200, Turkey (Türkiye)

  • Elazığ Mental Health and Diseases Hospital Psychiatry Clinic

    NOT_YET_RECRUITING

    Elâzığ, Elâzığ, 23200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.